A novel homozygous mutation in ERLIN1 gene causing spastic paraplegia 62 and literature review |
| |
| Affiliation: | 1. Department of Neurology, Shanghai Jiao Tong University Affiliated Sixth People''s Hospital, Shanghai, China;2. Department of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China;3. Department of Neurology, Suzhou Hospital of Anhui Medical University (Suzhou Municipal Hospital of Anhui Province), Anhui, China;4. Department of Neurology, Shanghai Fengxian District Central Hospital, Shanghai Jiao Tong University Affiliated Sixth People''s Hospital South Campus, Shanghai, China;1. First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, 450000, China;2. Medical College of Pediatrics, Henan University of Traditional Chinese Medicine, Zhengzhou, 450000, China;1. Department of Neurology, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium;2. Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, 9000, Ghent, Belgium;3. Center for Medical Genetics, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium;1. Dermatology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain;2. IRB Lleida, Spain;3. Medical Oncology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain;4. Endocrinology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain;5. General Surgery Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain;6. Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova, Lleida, Spain;7. Laboratori Clínic ICS Lleida, Hospital Universitari Arnau de Vilanova, Lleida, Spain;8. Centre of Biomedical Research on Cancer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain;9. University of Lleida, Spain |
| |
| Abstract: | ![]()
Hereditary spastic paraplegia (HSP) is a group of genetic neurodegenerative disorders, which is characterized by the presence of progressive spasticity and weakness in bilateral lower limbs. Spastic paraplegia 62 (SPG62) caused by the endoplasmic reticulum lipid raft associated 1 (ERLIN1) gene mutation is a rare subtype of HSP. Herein, we report the case of the first Chinese SPG62 patient, explore the potential pathogenic mechanism and review ERLIN1-related HSP patients. A 23-year-old man had progressive difficulty in walking and gait abnormalities for more than 11 years. Physical examination showed slightly reduced muscle strength (5-/5) and elevated muscle tone in the lower limbs and hyperreflexia in four limbs. Genetic analysis identified a novel splicing site mutation in ERLIN1 gene (c.504+1G > A), which was predicted to disturb the normal splicing process of mRNA by bioinformatic tools. Minigene experiment further confirmed the mutation c.504+1G > A could cause erroneous deletion of Exon 7 in the mRNA, which may change the conserved prohibitin (PHB) domain of erlin-1 and affect the function of erlin1/2 complex. Thus, we identified a pathogenic mutation of ERLIN1 splicing site causing delayed-onset pure HSP. This study widened the genetic and phenotypic spectrum of SPG62. |
| |
| Keywords: | Minigene Spastic paraplegia SPG62 Whole exome sequencing |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
